Michael Kammüller

1.1k citations

43 papers · 772 indexed · h-index 20

Impact in

Immunology top 5%
- Immunotoxicology and immune responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
Small Animals top 5%
- Animal testing and alternatives

Papers in

Immunology 27
- Complement system in diseases 6
- Immune Cell Function and Interaction 5
- Immunotoxicology and immune responses 4
- Immunotherapy and Immune Responses 4
Microbiology 4

Co-authors: Willem Seinen Nanne Bloksma Dominique Brees C. Thomas Salah‐Dine Chibout Bernhard Ryffel Todd Fox Ainhoa Arbués
Journals: Frontiers in Immunology (6 papers)Food and Chemical Toxicology (3 papers)PLoS Pathogens (3 papers)Blood (2 papers)Journal of Pharmaceutical Sciences (1 paper)
Partner nations: Switzerland Netherlands United Kingdom

In The Last Decade

Michael Kammüller

43 papers receiving 738 citations

Peers

Countries citing papers authored by Michael Kammüller

Since Specialization

Citations

This map shows the geographic impact of Michael Kammüller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kammüller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kammüller more than expected).

Fields of papers citing papers by Michael Kammüller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kammüller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kammüller. The network helps show where Michael Kammüller may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Kammüller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Kammüller Line = papers co-authored together Michael Kammüller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway Frontiers in Immunology ·Emma Ispasanie, Lukas Muri, Marc Schmid, Anna Schubart, Christine Thorburn, Natasa Zamurovic, Thomas Holbro, Michael Kammüller, Gerd Pluschke	2023	5
2	An Intra-Company Analysis of Inherent Particles in Biologicals Shapes the Protein Particle Mitigation Strategy Across Development Stages Journal of Pharmaceutical Sciences ·Sorina Morar-Mitrica, Thomas Pohl, Dietmar Theisen, Björn Boll, Karoline Bechtold-Peters, Reinhard Schipflinger, Beate Beyer, Swen Zierow, Michael Kammüller, Andreas B. Pribil, Bernhard Schmelzer, Stephan Boehm, Micheline Goetti, Tim Serno	2023	4
3	Patients with naproxen‐induced liver injury display T‐cell memory responses toward an oxidative (S)‐O‐desmethyl naproxen metabolite but not the acyl glucuronide Allergy ·Paul Thomson, Nik Fragkas, Laila Kafu, Guruprasad P. Aithal, M. Isabel Lucena, Luigi Terracciano, Xiaoli Meng, Munir Pirmohamed, Dominique Brees, Gerd A. Kullak‐Ublick, Alex Odermatt, Thomas Hammond, Michael Kammüller, Dean J. Naisbitt	2023	5
4	Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against Haemophilus influenzae type b Frontiers in Immunology ·Lukas Muri, Anna Schubart, Christine Thorburn, Natasa Zamurovic, Thomas Holbro, Michael Kammüller, Gerd Pluschke, Emma Ispasanie	2022	7
5	Alternative Complement Pathway Inhibition Abrogates Pneumococcal Opsonophagocytosis in Vaccine-Naïve, but Not in Vaccinated Individuals Frontiers in Immunology ·Lukas Muri, Emma Ispasanie, Anna Schubart, Christine Thorburn, Natasa Zamurovic, Thomas Holbro, Michael Kammüller, Gerd Pluschke	2021	19
6	Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals Frontiers in Immunology ·Emma Ispasanie, Lukas Muri, Anna Schubart, Christine Thorburn, Natasa Zamurovic, Thomas Holbro, Michael Kammüller, Gerd Pluschke	2021	21
7	Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice PLoS Pathogens ·Nicole Caduff, Donal McHugh, Anita Murer, Patrick C. Rämer, Ana Raykova, Vanessa Landtwing, Lisa Rieble, Christian W. Keller, Michael Prummer, Laurent Hoffmann, Janice K. P. Lam, Aks Chiang, Friedrich Raulf, Tarik Azzi, Christoph Berger, Tina Rubic-Schneider, Elisabetta Traggiai, Jan D. Lünemann, Michael Kammüller, Christian Münz	2020	16
8	The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases Frontiers in Immunology ·José M. Carballido, Camille Regairaz, Céline Rauld, Layla Raad, D Picard, Michael Kammüller	2020	23
9	TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis PLoS Pathogens ·Ainhoa Arbués, Dominique Brees, Salah‐Dine Chibout, Todd Fox, Michael Kammüller, Damien Portevin	2020	34
10	Inhibition of IL‐17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections Clinical & Translational Immunology ·Michael Kammüller, Tsen‐Fang Tsai, C.E.M. Griffiths, Nidhi Kapoor, Pappachan E. Kolattukudy, Dominique Brees, Salah‐Dine Chibout, Jorge Safi, Todd Fox	2017	57
11	Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization Scientific Reports ·Noria Segueni, Elaine Tritto, Marie-Laure Bourigault, Stéphanie Rose, François Erard, Marc Le Bert, Muazzam Jacobs, Franco Di Padova, Daniel P. Stiehl, Pierre Moulin, Dominique Brees, Salah‐Dine Chibout, Bernhard Ryffel, Michael Kammüller, Valérie Quesniaux	2016	33
12	Regulation of Allergic Responses to Chemicals and Drugs: Possible Roles of Epigenetic Mechanisms Toxicological Sciences ·Jonathan G. Moggs, Rémi Terranova, Michael Kammüller, Salah-Dine Chibout, V. Chapman, Rebecca J. Dearman, Ian Kimber	2012	11
13	Investigative safety science as a competitive advantage for Pharma Expert Opinion on Drug Metabolism & Toxicology ·Jonathan G. Moggs, Pierre Moulin, François Pognan, Dominique Brees, Michele Leonard, Steve Busch, André Cordier, David Heard, Michael Kammüller, Michael Merz, Page Bouchard, Salah‐Dine Chibout	2012	13
14	Extrapolation of Experimental Safety Data to Humans: The Interleukin-6 Case Clinical Immunology and Immunopathology ·Michael Kammüller, Bernhard Ryffel	1997	8
15	Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology Food and Chemical Toxicology ·D. A. Basketter, Jan Ν. Bremmer, Patrick J. Buckley, Michael Kammüller, Takami Kawabata, Ian Kimber, Scott E. Loveless, Stephen Magda, D.A. Stringer, H.-W. Vohr	1995	22
16	The identification of chemicals with sensitizing or immunosuppressive properties in routine toxicology Food and Chemical Toxicology ·D. A. Basketter, Jan Ν. Bremmer, Michael Kammüller, Takami Kawabata, Ian Kimber, Scott E. Loveless, Stephen Magda, T.H.M. Pal, D.A. Stringer, H.-W. Vohr	1994	15
17	Long-term treatment with 5,5-diphenylhydantoin reduces lymphadenopathy and anti-ssDNA autoantibodies in C57BL/6-lpr/lpr mice International Journal of Immunopharmacology ·Nanne Bloksma, J.M. De Bakker, H.J.M. van Rooijen, Peter J. Punt, Willem Seinen, Michael Kammüller	1994	5
18	V_β repertoire in rats and implications for endogenous superantigens European Journal of Immunology ·Lawrence Smith, Dwight H. Kono, Michael Kammüller, Robert Balderas, Argyrios N. Theofilopoulos	1992	25
19	The popliteal lymph node assay in mice to screen for the immune disregulating potential of chemicals — A preliminary study International Journal of Immunopharmacology ·Michael Kammüller, C. Thomas, J.M. De Bakker, Nanne Bloksma, Willem Seinen	1989	69
20	1-phenyl-5-vinyl-2-imidazolidinethione, a proposed causative agent of Spanish toxic oil syndrome: Synthesis, and identification in one of a group of case-associated oil samples Food and Chemical Toxicology ·Michael Kammüller, Henk J. M. Verhaar, Cees Versluis, J. K. Terlouw, L. Brandsma, A.H. Penninks, Willem Seinen	1988	11

About Michael Kammüller

Michael Kammüller is a scholar working on Immunology, Microbiology, Hematology, Infectious Diseases and Transplantation, having authored 43 papers that have together received 772 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (7 papers), Complement system in diseases (6 papers), Mycobacterium research and diagnosis (6 papers), Immune Cell Function and Interaction (5 papers), Immunotoxicology and immune responses (4 papers), Asthma and respiratory diseases (4 papers), Pneumonia and Respiratory Infections (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (453 citations), Small Animals (89 citations), Dermatology (90 citations), Hematology (88 citations) and Infectious Diseases (124 citations). Michael Kammüller has collaborated with scholars based in Switzerland, Netherlands and United Kingdom. Frequent co-authors include Willem Seinen, Nanne Bloksma, Dominique Brees, C. Thomas, Salah‐Dine Chibout, Bernhard Ryffel, Todd Fox, Ainhoa Arbués, Damien Portevin and Tina Rubic-Schneider. Their work appears in journals such as Frontiers in Immunology, Food and Chemical Toxicology, PLoS Pathogens, Blood and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact